تفاصيل الأصول
MbrlCatalogueTitleDetail
هل ترغب في حجز الكتاب؟
Randomised clinical trials in critical care: past, present and future
في
Bayesian analysis
/ Clinical trials
/ Critical care
/ Evidence-based medicine
/ Heterogeneity
/ History of medicine
/ Medical research
/ Patient-centered care
/ Randomization
/ Standardization
/ Statistical analysis
2022
لقد وضعنا الحجز لك!
بالمناسبة ، لماذا لا تستكشف الفعاليات التي يمكنك حضورها عند زيارتك للمكتبة لإستلام كتبك
أنت حاليًا في قائمة الانتظار لالتقاط هذا الكتاب. سيتم إخطارك بمجرد انتهاء دورك في التقاط الكتاب
هل أنت متأكد أنك تريد إزالة الكتاب من الرف؟
Randomised clinical trials in critical care: past, present and future
بواسطة
في
Bayesian analysis
/ Clinical trials
/ Critical care
/ Evidence-based medicine
/ Heterogeneity
/ History of medicine
/ Medical research
/ Patient-centered care
/ Randomization
/ Standardization
/ Statistical analysis
2022
وجه الفتاة! هناك خطأ ما.
أثناء محاولة إزالة العنوان من الرف ، حدث خطأ ما :( يرجى إعادة المحاولة لاحقًا!
وجه الفتاة! هناك خطأ ما.
أثناء محاولة إضافة العنوان إلى الرف ، حدث خطأ ما :( يرجى إعادة المحاولة لاحقًا!
هل تريد طلب الكتاب؟
Randomised clinical trials in critical care: past, present and future
في
Bayesian analysis
/ Clinical trials
/ Critical care
/ Evidence-based medicine
/ Heterogeneity
/ History of medicine
/ Medical research
/ Patient-centered care
/ Randomization
/ Standardization
/ Statistical analysis
2022
يرجى العلم أن الكتاب الذي طلبته لا يمكن استعارته. إذا كنت ترغب في إستعارة هذا الكتاب ، يمكنك حجز نسخة أخرى
Journal Article
Randomised clinical trials in critical care: past, present and future
2022
الطلب من المخزن الآلي
واختر طريقة الاستلام
نظرة عامة
Randomised clinical trials (RCTs) are the gold standard for providing unbiased evidence of intervention effects. Here, we provide an overview of the history of RCTs and discuss the major challenges and limitations of current critical care RCTs, including overly optimistic effect sizes; unnuanced conclusions based on dichotomization of results; limited focus on patient-centred outcomes other than mortality; lack of flexibility and ability to adapt, increasing the risk of inconclusive results and limiting knowledge gains before trial completion; and inefficiency due to lack of re-use of trial infrastructure. We discuss recent developments in critical care RCTs and novel methods that may provide solutions to some of these challenges, including a research programme approach (consecutive, complementary studies of multiple types rather than individual, independent studies), and novel design and analysis methods. These include standardization of trial protocols; alternative outcome choices and use of core outcome sets; increased acceptance of uncertainty, probabilistic interpretations and use of Bayesian statistics; novel approaches to assessing heterogeneity of treatment effects; adaptation and platform trials; and increased integration between clinical trials and clinical practice. We outline the advantages and discuss the potential methodological and practical disadvantages with these approaches. With this review, we aim to inform clinicians and researchers about conventional and novel RCTs, including the rationale for choosing one or the other methodological approach based on a thorough discussion of pros and cons. Importantly, the most central feature remains the randomisation, which provides unparalleled restriction of confounding compared to non-randomised designs by reducing confounding to chance.
الناشر
Springer Nature B.V
يستخدم هذا الموقع ملفات تعريف الارتباط لضمان حصولك على أفضل تجربة على موقعنا.